SCHEMBL17873647

SCHEMBL17873647

C[C@H](O)CS(=O)(=O)Nc1cccc(C(CN2CCCC2)N(C)C(=O)Cc2ccc(C(F)(F)F)cc2)c1

nearest known ligand 0.83

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
OPRK1 P41145 15/20 0.83
OPRD1 P41143 3/20 0.53
CYP2D6 P10635 2/20 0.52
OPRM1 P35372 1/20 0.52
CYP3A4 P08684 1/20 0.52
TSHR P16473 1/20 0.52
CYP2C19 P33261 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17873637 1.00 OPRK1 (0.83) OPRK1OPRD1CYP2D6OPRM1CYP3A4
SCHEMBL19739295 1.00 OPRK1 (0.83) OPRK1OPRD1CYP2D6OPRM1CYP3A4
Hydrochloric Acid SCHEMBL6479735 0.90 OPRK1 (0.98) OPRK1OPRD1CYP2D6OPRM1
Hydrochloric Acid SCHEMBL6479733 0.90 OPRK1 (0.98) OPRK1OPRD1CYP2D6OPRM1
SCHEMBL17883750 0.88 OPRK1 (0.72) OPRK1OPRD1CYP2D6OPRM1
SCHEMBL19739305 0.88 OPRK1 (0.72) OPRK1OPRD1CYP2D6OPRM1
SCHEMBL17883540 0.87 OPRD1 (0.71) OPRK1OPRD1CYP2D6OPRM1CYP3A4
SCHEMBL19739359 0.87 OPRD1 (0.71) OPRK1OPRD1CYP2D6OPRM1CYP3A4
SCHEMBL21119545 0.85 OPRK1 (0.73) OPRK1OPRD1CYP2D6CYP3A4TSHR
SCHEMBL7692832 0.83 OPRK1 (0.91) OPRK1OPRD1CYP2D6OPRM1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3237388-A1 N-METHYL-N-(1-PHENYL-2-(1-PYRROLIDINYL)ETHYL)-2-AMINOPHENYLACETAMIDE DERIVATIVES AGONISTS FOR THE KAPPA OPIOID RECEPTOR Nektar Therapeutics (US) 2017-11-01 EP disclosed
WO-2016106133-A1 N-METHYL-N-(1-PHENYL-2-(1-PYRROLIDINYL)ETHYL)-2-AMINOPHENYLACETAMIDE DERIVATIVES AGONISTS FOR THE KAPPA OPIOID RECEPTOR NEKTAR THERAPEUTICS (US) 2016-06-30 WO disclosed